Genzyme Corporation drugs

17 results

  • aldurazyme - laronidase injection, solution, concentrate

    (Laronidase)
    Genzyme Corporation
    Aldurazyme treats adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I), and Scheie form MPS I patients with moderate to severe symptoms.
    Medication Details
    Drug Interactions

  • aubagio - teriflunomide tablet, film coated

    (Teriflunomide)
    Genzyme Corporation
    Aubagio treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
    Medication Details
    Drug Interactions

  • cablivi - caplacizumab

    (Caplacizumab)
    Genzyme Corporation
    Cablivi treats acquired thrombotic thrombocytopenic purpura (aTTP) in adults and pediatric patients 12 and older, used alongside plasma exchange and immunosuppressive therapy.
    Medication Details

  • caprelsa - vandetanib tablet, film coated

    (Vandetanib)
    Genzyme Corporation
    Caprelsa treats symptomatic or progressive medullary thyroid cancer in adults with unresectable locally advanced or metastatic disease. Use with caution in patients with indolent, asymptomatic, or slowly progressing disease due to treatment-related risks.
    Medication Details
    Drug Interactions

  • cerdelga - eliglustat capsule

    (Eliglustat)
    Genzyme Corporation
    Cerdelga is indicated for long-term treatment of adults with Gaucher disease type 1 (GD1) who are CYP2D6 extensive, intermediate, or poor metabolizers as detected by an FDA-cleared test.
    Medication Details
    Drug Interactions

  • cerezyme - imiglucerase injection, powder, lyophilized, for solution

    (Imiglucerase)
    Genzyme Corporation
    Cerezyme treats non-central nervous system manifestations of Type 1 and Type 3 Gaucher disease in adults and pediatric patients.
    Medication Details

  • lemtrada - alemtuzumab injection, solution, concentrate

    (Alemtuzumab)
    Genzyme Corporation
    Lemtrada treats relapsing forms of multiple sclerosis—including relapsing-remitting and active secondary progressive disease—in adults. Due to its safety profile, it is generally reserved for patients who have not responded adequately to two or more other MS medications. Not recommended for clinically isolated syndrome.
    Medication Details
    Drug Interactions

  • lumizyme - alglucosidase alfa injection, powder, for solution

    (Alglucosidase Alfa)
    Genzyme Corporation
    Lumizyme is indicated for patients with Pompe disease (acid alpha-glucosidase deficiency), a rare genetic condition affecting lysosomal glycogen breakdown.
    Medication Details